Eversept Partners, LP Biocryst Pharmaceuticals Inc Transaction History

Eversept Partners, LP

  • $993 Million
  • Q2 2025

A detailed history of Eversept Partners, LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Eversept Partners, LP holds 1,207,638 shares of BCRX stock, worth $8.37 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
1,207,638
Previous 2,172,436 44.41%
Holding current value
$8.37 Million
Previous $16.3 Million 33.59%
% of portfolio
1.09%
Previous 1.8%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$6.41 - $11.19 $6.18 Million - $10.8 Million
-964,798 Reduced 44.41%
1,207,638 $10.8 Million
Q1 2025

May 15, 2025
BUY
$7.06 - $9.39 $1.36 Million - $1.8 Million
192,124 Added 9.7%
2,172,436 $16.3 Million
Q4 2024

Feb 14, 2025
BUY
$7.03 - $8.43 $10.2 Million - $12.2 Million
1,444,907 Added 269.87%
1,980,312 $14.9 Million
Q3 2024

Nov 14, 2024
SELL
$6.41 - $8.69 $3.96 Million - $5.36 Million
-617,168 Reduced 53.55%
535,405 $4.07 Million
Q2 2024

Aug 14, 2024
SELL
$4.13 - $6.79 $1.16 Million - $1.9 Million
-279,854 Reduced 19.54%
1,152,573 $7.12 Million
Q1 2024

May 15, 2024
SELL
$4.89 - $7.65 $472,471 - $739,143
-96,620 Reduced 6.32%
1,432,427 $7.28 Million
Q4 2023

Feb 14, 2024
SELL
$4.98 - $6.77 $4.73 Million - $6.43 Million
-950,056 Reduced 38.32%
1,529,047 $9.16 Million
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $717,902 - $847,360
106,990 Added 4.51%
2,479,103 $17.6 Million
Q2 2023

Nov 08, 2023
SELL
$6.96 - $8.81 $15 Million - $18.9 Million
-2,148,611 Reduced 47.53%
2,372,113 $16.7 Million
Q2 2023

Aug 14, 2023
SELL
$6.96 - $8.81 $15 Million - $18.9 Million
-2,148,611 Reduced 47.53%
2,372,113 $16.7 Million
Q1 2023

Nov 08, 2023
BUY
$7.94 - $11.84 $28.9 Million - $43.1 Million
3,640,237 Added 413.43%
4,520,724 $37.7 Million
Q1 2023

May 15, 2023
BUY
$7.94 - $11.84 $28.9 Million - $43.1 Million
3,640,237 Added 413.43%
4,520,724 $37.7 Million
Q4 2022

Nov 08, 2023
SELL
$10.5 - $14.2 $15.7 Million - $21.2 Million
-1,491,626 Reduced 62.88%
880,487 $10.1 Million
Q4 2022

Feb 14, 2023
BUY
$10.5 - $14.2 $9.25 Million - $12.5 Million
880,487 New
880,487 $10.1 Million
Q1 2021

May 13, 2021
SELL
$7.37 - $13.61 $3.62 Million - $6.69 Million
-491,852 Closed
0 $0
Q4 2020

Nov 08, 2023
SELL
$3.37 - $8.61 $6.34 Million - $16.2 Million
-1,880,261 Reduced 79.27%
491,852 $3.66 Million
Q4 2020

Feb 16, 2021
SELL
$3.37 - $8.61 $2.2 Million - $5.61 Million
-651,359 Reduced 56.98%
491,852 $3.66 Million
Q3 2020

Nov 08, 2023
SELL
$3.43 - $5.53 $12.7 Million - $20.5 Million
-3,704,581 Reduced 76.42%
1,143,211 $3.93 Million
Q3 2020

Nov 13, 2020
SELL
$3.43 - $5.53 $12.7 Million - $20.5 Million
-3,704,581 Reduced 76.42%
1,143,211 $3.93 Million
Q2 2020

Nov 08, 2023
SELL
$1.9 - $5.61 $5.12 Million - $15.1 Million
-2,694,580 Reduced 35.73%
4,847,792 $23.1 Million
Q2 2020

Aug 13, 2020
SELL
$1.9 - $5.61 $5.12 Million - $15.1 Million
-2,694,580 Reduced 35.73%
4,847,792 $23.1 Million
Q1 2020

Nov 08, 2023
BUY
$1.6 - $4.11 $4.22 Million - $10.8 Million
2,637,912 Added 53.79%
7,542,372 $15.1 Million
Q1 2020

May 13, 2020
BUY
$1.6 - $4.11 $4.22 Million - $10.8 Million
2,637,912 Added 53.79%
7,542,372 $15.1 Million
Q4 2019

Nov 08, 2023
BUY
$1.59 - $3.45 $6.76 Million - $14.7 Million
4,250,000 Added 649.39%
4,904,460 $16.9 Million
Q4 2019

Feb 13, 2020
BUY
$1.59 - $3.45 $6.76 Million - $14.7 Million
4,250,000 Added 649.39%
4,904,460 $16.9 Million
Q3 2019

Nov 08, 2023
BUY
$2.5 - $3.73 $780,000 - $1.16 Million
312,000 Added 91.11%
654,460 $1.88 Million
Q3 2019

Nov 13, 2019
BUY
$2.5 - $3.73 $780,000 - $1.16 Million
312,000 Added 91.11%
654,460 $1.88 Million
Q2 2019

Nov 08, 2023
SELL
$2.91 - $9.15 $204,910 - $644,306
-70,416 Reduced 17.05%
342,460 $1.3 Million
Q2 2019

Aug 13, 2019
SELL
$2.91 - $9.15 $204,910 - $644,306
-70,416 Reduced 17.05%
342,460 $1.3 Million
Q1 2019

Nov 08, 2023
BUY
$7.38 - $9.72 $1.84 Million - $2.42 Million
248,917 Added 151.82%
412,876 $3.36 Million
Q1 2019

May 14, 2019
BUY
$7.38 - $9.72 $1.84 Million - $2.42 Million
248,917 Added 151.82%
412,876 $3.36 Million
Q4 2018

Nov 08, 2023
BUY
$6.51 - $9.6 $97,650 - $144,000
15,000 Added 10.07%
163,959 $1.32 Million
Q4 2018

Feb 13, 2019
BUY
$6.51 - $9.6 $97,650 - $144,000
15,000 Added 10.07%
163,959 $1.32 Million
Q1 2018

Nov 08, 2023
SELL
$4.35 - $5.82 $9.67 Million - $12.9 Million
-2,223,154 Reduced 93.72%
148,959 $711 Million
Q1 2018

May 14, 2018
SELL
$4.35 - $5.82 $214,715 - $287,275
-49,360 Reduced 24.89%
148,959 $711,000
Q4 2017

Nov 08, 2023
SELL
$4.16 - $5.33 $9.04 Million - $11.6 Million
-2,173,794 Reduced 91.64%
198,319 $974 Million
Q4 2017

Feb 12, 2018
BUY
$4.16 - $5.33 $825,007 - $1.06 Million
198,319
198,319 $974,000

Others Institutions Holding BCRX

# of Institutions
313
Shares Held
201M
Call Options Held
930K
Put Options Held
553K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.29B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email